Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates

被引：19
|
作者：
Magee, Thomas V. [1 ]
Han, Seungil [2 ]
McCurdy, Sandra P. [3 ]
Thuy-Trinh Nguyen [6 ]
Granskog, Karl [6 ]
Marr, Eric S. [2 ]
Maguire, Bruce A. [4 ]
Huband, Michael D. [5 ]
Chen, Jinshan Michael [6 ]
Subashi, Timothy A. [4 ]
Shanmugasundaram, Veerabahu [7 ]
机构：
[1] Pfizer, Cardiovasc Metab & Endocrine Dis CVMED Chem, Cambridge, MA 02139 USA
[2] Pfizer Inc, Struct Biol & Biophys, Groton, CT 06340 USA
[3] Cubist Pharmaceut, Lexington, MA 02421 USA
[4] Pfizer Inc, Primary Pharmacol Grp, Groton, CT 06340 USA
[5] Astra Zeneca, Waltham, MA 02451 USA
[6] Pfizer Inc, Exploratory Discovery Chem, Groton, CT 06340 USA
[7] Pfizer Inc, Computat Chem, Groton, CT 06340 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 06期
关键词：
Bacterial resistance; cfr; erm; MLSb; MRSA; Macrolide; Carbamolide; Clarithromycin; Oxazolidinone; Linezolid; Ribosome X-ray; Deinococcus radiodurans; PEPTIDYL TRANSFERASE CENTER; ANTIBACTERIAL ACTIVITY; MACROLIDE RESISTANCE; ANTIBIOTICS; RIBOSOME; CLARITHROMYCIN; TELITHROMYCIN; PNEUMONIAE; INCREASES; DESIGN;
D O I：
10.1016/j.bmcl.2013.01.067
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel series of 3-O-carbamoyl erythromycin A derived analogs, labeled carbamolides, with activity versus resistant bacterial isolates of staphylococci (including macrolide and oxazolidinone resistant strains) and streptococci are reported. An (R)-2-aryl substituent on a pyrrolidine carbamate appeared to be critical for achieving potency against resistant strains. Crystal structures showed a distinct aromatic interaction between the (R)-2-aryl (3-pyridyl for 4d) substituent on the pyrrolidine and G2484 (G2505, Escherichia coli) of the Deinococcus radiodurans 50S ribosome (3.2 angstrom resolution). (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1727 / 1731
页数：5
相关论文
共 50 条
  • [31] In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, Including Macrolide- and Amikacin-Resistant Clinical Isolates
    Kim, Dae Hun
    Kim, Su-Young
    Huh, Hee Jae
    Lee, Nam Yong
    Koh, Won-Jung
    Jhun, Byung Woo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [32] Synthesis and antibacterial activity of novel 3-O-descladinosylazithromycin derivatives
    Yan, Mi
    Ma, Ruixin
    Jia, Li
    Venter, Henrietta
    Ma, Shutao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 874 - 884
  • [33] In Vitro Activity of a Novel Quinolone, UB-8902, Against Ofloxacin-Resistant Mycobacterium tuberculosis Isolates
    Tudo, Griselda
    Lopez-Gavin, Alexandre
    Portell-Buj, Elena
    Freixes, Joan
    Vila, Jordi
    Roman, Angely
    Rosa Monte, Maria
    Gonzalez-Martin, Julian
    MICROBIAL DRUG RESISTANCE, 2020, 26 (09) : 1019 - 1022
  • [34] ACTIVITY OF IMIPENEM AND AMIKACIN AGAINST CLINICAL ISOLATES OF STRAINS RESISTANT TO 3RD-GENERATION CEPHALOSPORINS
    DZIERZANOWSKA, D
    KAMINSKA, W
    PATZER, J
    LOPACIUK, U
    NOWAK, J
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 17 - 18
  • [35] Synthesis and antibacterial activity of novel 4"-O-arylalkylcarbamoyl and 4"-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives
    Ju, Yongjing
    Xian, Ruiqing
    Zhang, Ling
    Ma, Ruixin
    Cao, Jichao
    Ma, Shutao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) : 3272 - 3274
  • [36] In Vitro Antifungal Activity of Epigallocatechin 3-O-Gallate against Clinical Isolates of Dermatophytes
    Park, Bong Joo
    Taguchi, Hideaki
    Kamei, Katsuhiko
    Matsuzawa, Tetsuhiro
    Hyon, Suong-Hyu
    Park, Jong-Chul
    YONSEI MEDICAL JOURNAL, 2011, 52 (03) : 535 - 538
  • [37] Synthesis and antibacterial activity of 2-benzylidene-3-oxobutanamide derivatives against resistant pathogens
    Sood, Ankur
    Kesavan, Venkitasamy
    RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1817 - 1826
  • [38] Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates
    Montoya, Marhiah C.
    Beattie, Sarah
    Alden, Kathryn M.
    Krysan, Damian J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [39] Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae:: characterization of South African isolates
    Klugman, KP
    Capper, T
    Widdowson, CA
    Koornhof, HJ
    Moser, W
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) : 729 - 734
  • [40] The potent antibacterial activity of sitafloxacin against fluoroquinolone-resistant clinical isolates of Vibrio cholerae O1
    Okuda, Jun
    Ramamurthy, Thandavarayan
    Yamasaki, Shinji
    MICROBIOLOGY AND IMMUNOLOGY, 2007, 51 (04) : 467 - 469
12345